Through the Lens: What’s Next in Eye Care
Insights from SightLine at the American Society of Cataract and Refractive Surgery Annual Meeting 2026
Published April 25, 2026
Industry leaders share perspectives on emerging ophthalmology innovations, the challenges shaping the field, and the approaches driving progress in eye care. From advancing technologies to evolving treatment strategies, these conversations highlight how companies are working to improve outcomes for both physicians and patients.
Andrew Stewart
Bausch + Lomb
President Global Pharmaceuticals & International Consumer
Excimer laser for MIGS.
Bill Shields
VirtuaLens
VP of Global Sales
Hands-on learning with immersive IOL simulator.
Carol Kearney
Tenpoint Therapeutics
Chief Commercial Officer
Dual agent eye drops for presbyopia.
Cody McKenzie
Glaukos Corp.
VP, Global Marketing Strategy & Franchise Management
Advancing interventional glaucoma.
Jim Mazzo
Patient Square Capital
Senior Advisor
Overcoming hurdles with technology.
John Berdahl, MD
Balance Ophthalmics
Founder and Chair
Strategies for moving through the FDA.
Joseph Nathan, MD, MSc
ForSight Robotics
Co-Founder, President & Chief Medical Officer
Tackling the vision crisis.
Mark L. Baum
Harrow, Inc.
Founder, Chairman of the Board and Chief Executive Officer
Opioid and IV-free cataract surgery.
Shawn O’Neil
ViaLase, Inc.
Chief Executive Offer
Incision-free glaucoma procedures.
Warren Foust
STAAR Surgical
Interim co-CEO
Expanded labeling for EVO ICL.
